{"id":10599,"date":"2026-02-20T07:07:11","date_gmt":"2026-02-20T07:07:11","guid":{"rendered":"https:\/\/lemonn.co.in\/blog\/?p=10599"},"modified":"2026-02-20T07:07:13","modified_gmt":"2026-02-20T07:07:13","slug":"gaudium-ivf-ipo-gmp-today","status":"publish","type":"post","link":"https:\/\/lemonn.co.in\/blog\/ipo\/gaudium-ivf-ipo-gmp-today\/","title":{"rendered":"Gaudium IVF IPO GMP: Latest Grey Market Premium, Subscription & Listing Outlook"},"content":{"rendered":"
\"Gaudium<\/figure>\n\n\n

The Gaudium IVF IPO GMP<\/strong> is currently around \u20b98\u2013\u20b910 per share<\/strong>, indicating a potential listing gain of nearly 10\u201313%<\/strong> over the upper price band of \u20b979.<\/p>\n\n\n\n

If you\u2019re tracking this IPO for listing gains or long-term investment, here\u2019s a complete breakdown of the latest GMP, subscription status, IPO details, risks, and listing outlook<\/strong> – explained in simple terms.<\/p>\n\n\n\n

Gaudium IVF IPO: Key Details at a Glance<\/h2>\n\n\n\n
IPO Detail<\/strong><\/th>Information<\/strong><\/th><\/tr><\/thead>
Company Name<\/strong><\/td>Gaudium IVF & Women Health Ltd.<\/td><\/tr>
IPO Type<\/strong><\/td>SME IPO<\/td><\/tr>
Price Band<\/strong><\/td>\u20b975 \u2013 \u20b979 per share<\/td><\/tr>
Face Value<\/strong><\/td>\u20b910 per share<\/td><\/tr>
Lot Size<\/strong><\/td>1,600 shares<\/td><\/tr>
Minimum Investment (Retail)<\/strong><\/td>\u20b91,26,400 (1 lot at \u20b979)<\/td><\/tr>
Issue Size<\/strong><\/td>Approx. \u20b948\u201350 crore<\/td><\/tr>
IPO Open Date<\/strong><\/td>February 2026<\/td><\/tr>
IPO Close Date<\/strong><\/td>February 2026<\/td><\/tr>
Listing Platform<\/strong><\/td>NSE SME<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
\n

Always confirm final dates and numbers from NSE or the official RHP before investing.<\/p>\n<\/blockquote>\n\n\n\n

\n\n\n\n

Gaudium IVF IPO GMP Today<\/h2>\n\n\n\n

Latest Grey Market Premium (GMP)<\/h3>\n\n\n\n
Date<\/strong><\/th>GMP (\u20b9)<\/strong><\/th>Estimated Listing Price (\u20b9)<\/strong><\/th>Expected Gain (%)<\/strong><\/th><\/tr><\/thead>
20 Feb 2026<\/td>\u20b98.5<\/td>\u20b987.5<\/td>~10.8%<\/td><\/tr>
19 Feb 2026<\/td>\u20b910<\/td>\u20b989<\/td>~12.7%<\/td><\/tr>
Earlier Peak<\/td>\u20b915<\/td>\u20b994<\/td>~18.9%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

How Listing Price Is Estimated<\/h3>\n\n\n\n

Upper Price Band (\u20b979) + GMP (\u20b98.5) = \u20b987.5 Estimated Listing<\/strong><\/p>\n\n\n\n

\u26a0\ufe0f Important: GMP is unofficial and can change daily. It reflects market sentiment – not a guaranteed listing price.<\/p>\n\n\n\n

What Does This GMP Indicate?<\/h2>\n\n\n\n

A positive GMP usually suggests:<\/p>\n\n\n\n

    \n
  • Strong investor interest<\/li>\n\n\n\n
  • Possible listing premium<\/li>\n\n\n\n
  • Healthy grey market demand<\/li>\n<\/ul>\n\n\n\n

    However, SME IPOs can be volatile. GMP can drop sharply before listing day.<\/p>\n\n\n\n

    Think of GMP as a \u201ctemperature check\u201d – not a final result.<\/p>\n\n\n\n

    Gaudium IVF IPO Subscription Status<\/h2>\n\n\n\n

    (Indicative category-wise interest)<\/p>\n\n\n\n

    Investor Category<\/strong><\/th>Subscription (Approx.)<\/strong><\/th><\/tr><\/thead>
    Retail Investors (RII)<\/td>3\u20135x<\/td><\/tr>
    HNI\/NII<\/td>4\u20136x<\/td><\/tr>
    QIB<\/td>Limited (SME IPO structure)<\/td><\/tr>
    Overall Subscription<\/strong><\/td>4\u20136x (Approx.)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

    Higher subscription generally means tougher allotment chances and stronger listing expectations.<\/p>\n\n\n\n

    About Gaudium IVF & Women Health Ltd.<\/h2>\n\n\n\n

    Gaudium IVF operates in the fertility and women\u2019s healthcare segment<\/strong>, offering:<\/p>\n\n\n\n

      \n
    • IVF treatments<\/li>\n\n\n\n
    • Fertility preservation<\/li>\n\n\n\n
    • Women\u2019s health services<\/li>\n\n\n\n
    • Advanced reproductive technologies<\/li>\n<\/ul>\n\n\n\n

      India\u2019s fertility treatment market is growing due to:<\/p>\n\n\n\n

        \n
      • Rising infertility awareness<\/li>\n\n\n\n
      • Delayed parenthood trends<\/li>\n\n\n\n
      • Urban lifestyle changes<\/li>\n\n\n\n
      • Better medical technology<\/li>\n<\/ul>\n\n\n\n

        This sector has long-term growth potential, but it is also highly competitive.<\/p>\n\n\n\n

        Should You Apply for Listing Gains?<\/h2>\n\n\n\n

        If your goal is short-term listing gains:<\/p>\n\n\n\n

          \n
        • Positive GMP supports listing premium expectations<\/li>\n\n\n\n
        • Moderate subscription adds demand strength<\/li>\n\n\n\n
        • Healthcare sector has stable sentiment<\/li>\n<\/ul>\n\n\n\n

          But remember:<\/p>\n\n\n\n

            \n
          • SME stocks can hit upper or lower circuits quickly<\/li>\n\n\n\n
          • Liquidity can be limited<\/li>\n\n\n\n
          • Volatility is higher than mainboard IPOs<\/li>\n<\/ul>\n\n\n\n

            Risks to Consider<\/h2>\n\n\n\n

            Before investing, understand the risks:<\/p>\n\n\n\n

              \n
            • SME IPO liquidity risk<\/li>\n\n\n\n
            • Dependence on fertility treatment demand<\/li>\n\n\n\n
            • Regulatory changes in healthcare<\/li>\n\n\n\n
            • Competition from established IVF chains<\/li>\n<\/ul>\n\n\n\n

              Never invest based only on GMP hype.<\/p>\n\n\n\n

              Listing Day Strategy<\/h2>\n\n\n\n

              Here are three practical approaches investors use:<\/p>\n\n\n\n

              Conservative Strategy<\/h3>\n\n\n\n

              Sell on listing if gain >10\u201315%.<\/p>\n\n\n\n

              Balanced Strategy<\/h3>\n\n\n\n

              Sell 50% on listing, hold 50% long term.<\/p>\n\n\n\n

              Long-Term Strategy<\/h3>\n\n\n\n

              Hold if company shows strong revenue growth and expansion plans.<\/p>\n\n\n\n

              Choose based on your risk appetite.<\/p>\n\n\n\n

              Final Verdict: Gaudium IVF IPO GMP Outlook<\/h2>\n\n\n\n

              The Gaudium IVF IPO GMP of \u20b98\u2013\u20b910<\/strong> suggests a possible 10\u201313% listing gain<\/strong>, but this is not guaranteed.<\/p>\n\n\n\n

              If subscription remains strong and market sentiment stays positive, listing could be stable to positive. However, SME IPOs carry higher volatility.<\/p>\n\n\n\n

              Do your own research. Align your decision with your financial goals – not just grey market trends.<\/p>\n\n\n\n

              Frequently Asked Questions (FAQs)<\/h2>\n\n\n
              \n
              \n
              \n

              Q. What is the Gaudium IVF IPO GMP today?<\/h3>\n
              \n\n

              Currently around \u20b98\u2013\u20b910 per share.<\/p>\n\n<\/div>\n<\/div>\n

              \n

              Q. Is GMP reliable?<\/h3>\n
              \n\n

              No. It\u2019s unofficial and can change daily.<\/p>\n\n<\/div>\n<\/div>\n

              \n

              Q. What is the minimum investment?<\/h3>\n
              \n\n

              \u20b91,26,400 for 1 retail lot.<\/p>\n\n<\/div>\n<\/div>\n

              \n

              Q. Is Gaudium IVF IPO good for long term?<\/h3>\n
              \n\n

              Depends on revenue growth, expansion plans, and financial performance post-listing.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n

              Key Takeaways<\/h2>\n\n\n\n
                \n
              • GMP: \u20b98\u2013\u20b910 (approx.)<\/li>\n\n\n\n
              • Expected listing gain: 10\u201313%<\/li>\n\n\n\n
              • SME IPO – higher risk, higher volatility<\/li>\n\n\n\n
              • Don\u2019t rely only on GMP<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

                The Gaudium IVF IPO GMP is currently around \u20b98\u2013\u20b910 per share, indicating a potential listing gain of nearly 10\u201313% over the upper price band of \u20b979. If you\u2019re tracking this IPO for listing gains or long-term investment, here\u2019s a complete breakdown of the latest GMP, subscription status, IPO details, risks, and listing outlook – explained […]<\/p>\n","protected":false},"author":3,"featured_media":10600,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_ayudawp_aiss_exclude":false,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-10599","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/posts\/10599","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/comments?post=10599"}],"version-history":[{"count":1,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/posts\/10599\/revisions"}],"predecessor-version":[{"id":10601,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/posts\/10599\/revisions\/10601"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/media\/10600"}],"wp:attachment":[{"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/media?parent=10599"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/categories?post=10599"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/tags?post=10599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}